This announcement is a separate document:
中国医药：关于收购北京美康兴业生物技术有限公司77.97%股权暨关联交易公告
China Pharmaceutical: Announcement on the acquisition of 77.97% of Beijing Meikang Industrial Biotechnology Co., Ltd.'s shares and related transactions
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.